{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:56:05Z","timestamp":1794869765706,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Recurrence of community-associated (CA) <jats:italic toggle=\"yes\">Clostridiodes difficile<\/jats:italic> infection (CDI) approaches 30%. Studies on risk factors and treatment of choice for pediatric CA-CDI are scarce with variable recommendations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective cohort study of the electronic health records of children 1\u201317 years with stool specimens sent for <jats:italic toggle=\"yes\">C. difficile<\/jats:italic> at Kaiser Permanente Northern California from January 01, 2012 to December 31, 2016. Children with (1) CA disease, (2) confirmatory <jats:italic toggle=\"yes\">C. difficile<\/jats:italic> laboratory testing with no other identified causes of diarrhea and (3) clinical symptoms consistent with CDI were defined as cases. Recurrent CA-CDI was defined using the above-described case criteria and onset of diarrhea within 8 weeks of primary CA-CDI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 7350 children with stool samples sent for <jats:italic toggle=\"yes\">C. difficile<\/jats:italic> testing, 408 had primary CA-CDI. Forty-five (11%) experienced a recurrence. Using multivariable logistic regression, inflammatory bowel disease [odds ratio (OR) 7.5; 95% confidence interval (CI): 2.6\u201321.1] and cancer (OR 6.3; 95% CI: 1.6\u201324.1) diagnoses were risk factors for recurrent disease. Compared with children of Caucasian race, those with multi\/other\/unknown race had an OR of 3.03 (95% CI: 1.04\u20138.82) of recurrence. There was no statistically significant difference in the type or duration of therapy as a predictor for recurrent CA CDI. Six percent of children who received metronidazole were switched to vancomycin due to subjective metronidazole allergy or intolerance or metronidazole treatment failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Recurrent CA-CDI in children in our population is less common than previously reported. This study supports first-line treatment with the standard, short course metronidazole in most cases of primary CA-CDI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002439","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T09:16:18Z","timestamp":1571303778000},"page":"1073-1078","source":"Crossref","is-referenced-by-count":13,"title":["Risk Factors for Recurrent Community-associated Clostridiodes Difficile Infection in Children"],"prefix":"10.1097","volume":"38","author":[{"given":"Deepika","family":"Parmar","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Division of Infectious Diseases, Kaiser Permanente Northern California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dang","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Division of Infectious Diseases, Kaiser Permanente Northern California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Miranda-Katz","sequence":"additional","affiliation":[{"name":"Colby College, Waterville, Maine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Alabaster","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Division of Infectious Diseases, Kaiser Permanente Northern California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara L.","family":"Greenhow","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Division of Infectious Diseases, Kaiser Permanente Northern California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240429","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/520732","article-title":"Changing epidemiology of Clostridium difficile-associated disease in children.","volume":"28","author":"Benson","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R2-20240429","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/INF.0000000000000338","article-title":"A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.","volume":"33","author":"Crews","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20240429","first-page":"105","article-title":"Clostridium difficile: an emerging pathogen in children.","volume":"14","author":"Khalaf","year":"2012","journal-title":"Discov Med"},{"key":"R4-20240429","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/cid\/cit075","article-title":"The epidemiology of Clostridium difficile infection in children: a population-based study.","volume":"56","author":"Khanna","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R5-20240429","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.441","article-title":"Clostridium difficile infection in children.","volume":"167","author":"Sammons","year":"2013","journal-title":"JAMA Pediatr"},{"key":"R6-20240429","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/INF.0b013e31820bfb29","article-title":"Epidemiology and risk factors for Clostridium difficile infection in children.","volume":"30","author":"Sandora","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20240429","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/cid\/cit581","article-title":"Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.","volume":"57","author":"Tschudin-Sutter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R8-20240429","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1542\/peds.2013-3049","article-title":"Clostridium difficile infection among children across diverse US geographic locations.","volume":"133","author":"Wendt","year":"2014","journal-title":"Pediatrics"},{"key":"R9-20240429","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3201\/eid1604.090680","article-title":"Clostridium difficile infections among hospitalized children, United States, 1997-2006.","volume":"16","author":"Zilberberg","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R10-20240429","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2013.7056","article-title":"Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.","volume":"173","author":"Chitnis","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R11-20240429","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R12-20240429","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MPG.0000000000000553","article-title":"Novel risk factors for recurrent Clostridium difficile infection in children.","volume":"60","author":"Nicholson","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R13-20240429","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/INF.0000000000000108","article-title":"Predictors of first recurrence of Clostridium difficile infections in children.","volume":"33","author":"Tschudin-Sutter","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20240429","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jpeds.2015.04.052","article-title":"Risk factors for recurrent Clostridium difficile infection in children: a Nested Case-Control Study.","volume":"167","author":"Kociolek","year":"2015","journal-title":"J Pediatr"},{"key":"R15-20240429","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA).","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R16-20240429","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1542\/peds.2012-2992","article-title":"Clostridium difficile infection in infants and children.","volume":"131","author":"Schutze","year":"2013","journal-title":"Pediatrics"},{"key":"R17-20240429","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation.","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"R18-20240429","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/MIB.0000000000000219","article-title":"Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study.","volume":"20","author":"Martinelli","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R19-20240429","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1128\/AAC.00661-13","article-title":"Vancomycin use for pediatric Clostridium difficile infection is increasing and associated with specific patient characteristics.","volume":"57","author":"Schwenk","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20240429","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1001\/jamainternmed.2015.4114","article-title":"Overdiagnosis of Clostridium difficile infection in the molecular test era.","volume":"175","author":"Polage","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R21-20240429","first-page":"349","article-title":"Clostridium difficile - pathogen or pest?.","volume":"5","year":"2000","journal-title":"Paediatr Child Health"},{"key":"R22-20240429","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jpeds.2008.10.016","article-title":"Presence of the epidemic North American pulsed field type 1 Clostridium difficile strain in hospitalized children.","volume":"154","author":"Toltzis","year":"2009","journal-title":"J Pediatr"},{"key":"R23-20240429","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006454-199507000-00009","article-title":"Role of Clostridium difficile in childhood diarrhea.","volume":"14","author":"Cerquetti","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"R24-20240429","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/INF.0000000000001008","article-title":"Clinical significance of Clostridium difficile in children less than 2 years old: a case-control study.","volume":"35","author":"Gonz\u00e1lez-Del Vecchio","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20240429","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-225","article-title":"The Kaiser Permanente Northern California Adult Member Health Survey.","volume":"20","author":"Gordon","year":"2016","journal-title":"Perm J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T19:01:47Z","timestamp":1714417307000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002439","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}